A pharmacoeconomic study of in-hospital treatment against community-acquired pneumonia;Estudio farmacoeconómico del tratamiento hospitalario de neumonía adquirida en la comunidad

Farmacia Hospitalaria

Volumn 28, Issue 1, 2004, Pages 29-35

  Bermejo Vicedo, Teresa ^a   Torralba Arranz, A ^b   Hidalgo Correas, F J ^a   Millan Santos I ^b   Rodriguez Morradan B ^b  

^a HOSPITAL SEVERO OCHOA   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

89 and 90 DRGs; Antibiotics; Computerized unit dose drug dispensing system; Cost minimization study; Costs; Inhaled bronchodilators; Study of drug use

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; BRONCHODILATING AGENT; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; MACROLIDE; MEROPENEM; PIPERACILLIN; QUINOLONE DERIVATIVE;

ANTIBIOTIC THERAPY; ARTICLE; AUTOMATION; COMMUNITY ACQUIRED PNEUMONIA; COST MINIMIZATION ANALYSIS; DIAGNOSIS RELATED GROUP; DRUG COST; DRUG USE; HOSPITAL COST; HOSPITALIZATION; HUMAN; KOLMOGOROV SMIRNOV TEST; PRESCRIPTION; RANK SUM TEST; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BRONCHODILATOR AGENTS; COMMUNITY-ACQUIRED INFECTIONS; COST CONTROL; DRUG COSTS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; HOSPITAL COSTS; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; MALE; MEDICATION SYSTEMS, HOSPITAL; MIDDLE AGED; PNEUMONIA; RETROSPECTIVE STUDIES; SPAIN;

EID: 2142767009     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Sobradillo V. Etiología de la neumonía de la comunidad en España. Arch Bronconeumol 1993; 29: 365-6.
2. Woodhead M, et al. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987; 1: 671-4.
3. Monge V, San Martín M, González A. The burden of community -acquired pneumonia in Spain. European Journal of Public Health 2001; 11 (4): 362-4.
4. Gil A, San Martín M, Carrasco P, González A. Epidemiology of pneumonia hospitalizations in Spain 1995-98. Journal of Infection 2002; 44: 84-7.
5. Garibaldi RA. Epidemiology of community-acquired respiratory tract infections in adults. Am J Med 1985; 78 (Supl. 6B): 32-7.
6. Fine MJ, et al. Prognosis and outcomes of patients with community acquired pneumonia. A meta-analysis. JAMA 1995; 274: 134-41.
7. Macfariane JT. Community acquired pneumonia. Br J Dis Chest 1987; 81: 116-27.
8. Conjunto Mínimo Básico de Datos. Hospitales del Insalud 2001. Ministerio Sanidad y Consumo. Instituto Nacional de la Salud. Subdirección General de Desarrollo. Madrid 2002.
9. a ed. Granada. Escuela Andaluza de Salud Pública 1998.-(Monografía de la EASP; 24). Editor Rafael Burgos.
10. Martín Andrés A, Luna del Castillo J. de D. Bioestadística para las Ciencias de la Salud. Ediciones Norma S.A., 1994.
11. Blanco B, Morán D, Fernández MA, Martín ML y Domínguez Gil A. Análisis comparativo del GRD 90 en dos Servicios clínicos, un caso de homogeneidad. Farm Hosp 1999; 23 (Esp Cong): 48-9.
12. Soler Soler MM, San Miguel Zamora MT, Guadarrama I, Vázquez Polo A. Estudio retrospectivo coste por proceso GRDs 89 y 90. Farm Hosp 1999; 23 (Esp Cong): 43.
13. Gamundi MC, et al. Estudio multicéntrico sobre utilización de medicamentos en los GRD's 89, 90 y 91. Farm Hosp 1997; 21 (6): 316-23.